{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T13:53:14Z","timestamp":1761918794924},"reference-count":25,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2006,2,22]],"date-time":"2006-02-22T00:00:00Z","timestamp":1140566400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intl Journal of Cancer"],"published-print":{"date-parts":[[2006,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The prediction of <jats:italic>Helicobacter pylori<\/jats:italic> antibodies immunoglobulin A (IgA) and immunoglobulin G (IgG) and serum pepsinogen I (PG I) on gastric cancer occurrence was studied in a nested case\u2010control study, based on 225 incident cancer cases and 435 matched controls from a Finnish cohort followed from 1966\u20131991. The odds ratio of noncardia gastric cancer between infected and noninfected persons was 3.12 (95% confidence interval (CI) = 1.97\u20134.95) for elevated IgA and 2.88 (CI: 1.63\u20135.07) for elevated IgG antibodies. The odds ratio between low and high PG I was 2.24 (CI: 1.43\u20133.49). The strength of association was significant for IgA antibodies during the total follow\u2010up, but for IgG antibodies this was only true for follow\u2010up periods of 15 years or more. IgA antibodies were significantly associated with all registered histological subtypes apart from intestinal type adenocarcinoma. The highest gastric cancer risk was found among individuals with simultaneously elevated IgA and IgG antibodies and low PG I with an odds ratio of 10.9 (CI: 4.31\u201327.7) in comparison with those who were negative for both antibodies and had normal PG I. Elevated IgA and IgG antibodies and low PG I were not associated with cancers of the gastric cardia. The findings support the hypothesis that <jats:italic>H. pylori<\/jats:italic> infection is a cause of noncardia gastric cancer. Although elevated <jats:italic>H. pylori<\/jats:italic> IgA and IgG antibodies and low PG I independently could predict the occurrence of noncardia gastric cancer, their power to do so varied with the stage and length of the follow\u2010up period and it increased when they were applied in combination. \u00a9 2006 Wiley\u2010Liss, Inc.<\/jats:p>","DOI":"10.1002\/ijc.21884","type":"journal-article","created":{"date-parts":[[2006,2,23]],"date-time":"2006-02-23T00:17:05Z","timestamp":1140653825000},"page":"702-705","source":"Crossref","is-referenced-by-count":27,"title":["<i>Helicobacter pylori<\/i> IgA and IgG antibodies, serum pepsinogen I and the risk of gastric cancer: Changes in the risk with extended follow\u2010up period"],"prefix":"10.1002","volume":"119","author":[{"given":"Paul","family":"Knekt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lyly","family":"Teppo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arpo","family":"Aromaa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harri","family":"Rissanen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timo U.","family":"Kosunen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,5,8]]},"reference":[{"key":"e_1_2_5_2_2","first-page":"4737","article-title":"Gastric precancerous process in a high risk population: cohort follow\u2010up","volume":"50","author":"Correa P","year":"1990","journal-title":"Cancer Res"},{"key":"e_1_2_5_3_2","first-page":"177","article-title":"Infection with Helicobacter pylori","volume":"61","author":"International Agency for Research on Cancer","year":"1994","journal-title":"IARC Monogr Eval Carcinog Risks Hum"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.49.3.347"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(92)90929-W"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a008901"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a114788"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.3109\/02841869409098430"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268897007565"},{"key":"e_1_2_5_10_2","first-page":"1091","article-title":"Serum pepsinogen I and the state of gastric mucosa in an Estonian population sample","volume":"19","author":"Tamm A","year":"1984","journal-title":"Scand J Gastroenterol"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910190308"},{"key":"e_1_2_5_12_2","first-page":"5","article-title":"Statistical methods in cancer research, volume 1: the analysis of case\u2010control studies","volume":"32","author":"Breslow NE","year":"1980","journal-title":"IARC Sci Publ"},{"key":"e_1_2_5_13_2","volume-title":"Statistical methods for rates and proportions","author":"Fleiss JL","year":"1981"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(98)70422-6"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.3109\/07853890009002036"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.33.6.1496-1500.1995"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.40.3.297"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1083-4389.2004.00222.x"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(91)90477-7"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.41.4.442"},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365529109103997"},{"key":"e_1_2_5_22_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365529109025032"},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.46.4.460"},{"key":"e_1_2_5_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(82)90176-7"},{"key":"e_1_2_5_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(67)91299-8"},{"key":"e_1_2_5_26_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0463.2003.1110604.x"}],"container-title":["International Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fijc.21884","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ijc.21884","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T18:58:38Z","timestamp":1696877918000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ijc.21884"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5,8]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,8]]}},"alternative-id":["10.1002\/ijc.21884"],"URL":"https:\/\/doi.org\/10.1002\/ijc.21884","archive":["Portico"],"relation":{},"ISSN":["0020-7136","1097-0215"],"issn-type":[{"value":"0020-7136","type":"print"},{"value":"1097-0215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,5,8]]}}}